2013 MCMi Regulatory Science Symposium Program

First Page		Document Content
Pharmacology United States Department of Health and Human Services Clinical pharmacology United States Public Health Service Influenza vaccine Influenza Center for Biologics Evaluation and Research Biomedical Advanced Research and Development Authority MedImmune Health Medicine Food and Drug Administration		2013 MCMi Regulatory Science Symposium Program Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 560,24 KB Share Document on Facebook

	Bisogna dunque distinguere gli autori sui quali si scrive e la cui influenza non è né esteriore né anteriore a quello che se ne dice, e (concezione più classica) gli autori che si leggono; ma questi, cosa mi viene da DocID: 1voIa - View Document
	NATIONAL ACTION PLAN TO PREVENT HEALTH CARE-ASSOCIATED INFECTIONS: ROAD MAP TO ELIMINATION APRIL 2013 PART 4: PHASE TWO – OUTPATIENT SETTINGS AND INFLUENZA VACCINATION OF HEALTH CARE PERSONNEL CHAPTER 5: AMBULATORY SUR DocID: 1vlcw - View Document
	Visterra Announces Publication of Data Demonstrating the Effectiveness of VIS410 Against Seasonal and Potential Pandemic Influenza Strains – Preclinical Studies Published in the Proceedings of the National Academy of S DocID: 1vla9 - View Document
	Influenza in People and Pigs • • • DocID: 1vkDg - View Document
	SHORT REPORT Parallel evolution of influenza across multiple spatiotemporal scales Katherine S Xue1,2, Terry Stevens-Ayers3, Angela P Campbell3†, Janet A Englund4,5, Steven A Pergam3,6,7, Michael Boeckh3,6,7, Jesse D DocID: 1vkyn - View Document